These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8821840)

  • 1. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
    McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
    Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines.
    Topley N; Petersen MM; Mackenzie R; Neubauer A; Stylianou E; Kaever V; Davies M; Coles GA; Jörres A; Williams JD
    Kidney Int; 1994 Sep; 46(3):900-9. PubMed ID: 7996812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S
    Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes.
    Douvdevani A; Rapoport J; Konforti A; Zlotnik M; Chaimovitz C
    Perit Dial Int; 1993; 13(2):112-7. PubMed ID: 8494931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
    Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT
    Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.
    Davies SJ; Suassuna J; Ogg CS; Cameron JS
    Kidney Int; 1989 Oct; 36(4):661-8. PubMed ID: 2811064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.
    Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL
    Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis.
    Fernandez de Castro M; Selgas R; Jimenez C; Auxiliadora Bajo M; Martinez V; Romero JR; de Alvaro F; Vara F
    Perit Dial Int; 1994; 14(3):265-70. PubMed ID: 7948240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis.
    Fieren MW
    Blood Purif; 1996; 14(2):179-87. PubMed ID: 8785034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients.
    Kimmel PL; Phillips TM; Lew SQ; Langman CB
    Kidney Int; 1996 May; 49(5):1407-12. PubMed ID: 8731107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro differentiation and characterization of human peritoneal macrophages from CAPD-peritonitis patients.
    Burger M; Almanasreh N; Bauermeister K; Knopf HP; Schollmeyer P; Dobos GJ
    Immunobiology; 1999 Feb; 200(1):62-76. PubMed ID: 10084696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
    Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
    Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.